ArticleThoracic cancer2020

Unexpected favorable outcome to sintilimab plus bevacizumab in an EGFR-mutated non-small cell lung cancer patient: A case report.

Yiruo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.